ghk-cu study october 2025 - 200MG (Topical) Peptide Therapy for Injury Repair:

Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: a systematic review and meta-analysis

Clinical evidence remains limited and outcomes vary by patient

A 2021 review published in Nutrients found that GLP-1 receptor agonist use was associated with reduced dietary intake of multiple micronutrients including B12, particularly in patients following calorie-restricted eating patterns, supporting the rationale for monitoring B12 status during treatment even in patients without pre-existing deficiency risk factors

Route Subcutaneous shot only

I view this volatility as due almost solely to the momentum factor unwind and having very little to do with the fundamental thesis